Burden of deep vein thrombosis in the outpatient setting following major orthopedic surgery

Annals of Pharmacotherapy

Volumn 42, Issue 9, 2008, Pages 1216-1221

  Nutescu, Edith A ^a   Shorr, Andrew F ^b,c   Farrelly, Eileen ^d   Horblyuk, Ruslan ^e   Happe, Laura E ^d,f   Franklin, Meg ^f  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d XCENDA   (United States)

^e GLAXOSMITHKLINE   (United States)

^f NONE

Author keywords

Costs; Deep vein thrombosis; Fondaparinux; Low molecular weight heparin; Orthopedic surgery; Outpatient prophylaxis; Pulmonary embolism; Warfarin

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST OF ILLNESS; DEEP VEIN THROMBOSIS; EMERGENCY WARD; FEMALE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; ORTHOPEDIC SURGERY; OUTPATIENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL MODEL; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

AGED; ANTICOAGULANTS; FEMALE; GUIDELINES AS TOPIC; HEALTH CARE COSTS; HUMANS; MALE; ORTHOPEDIC PROCEDURES; OUTCOME ASSESSMENT (HEALTH CARE); OUTPATIENTS; RETROSPECTIVE STUDIES; RISK FACTORS; VENOUS THROMBOSIS;

EID: 50249153972     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L135     Document Type: Article

References (16)

1. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 204;126(suppl):338S-400S.
2. American Academy of Orthopaedic Surgeons clinical guideline on prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. Rosemont, IL: American Academy of Orthopaedic Surgeons; 2007:63.
3. Oster G, Ollendorf DA, Vera-Llonch M, Hagiwara M, Berger A, Edelsberg J. Economic consequences of venous thromboembolism following major orthopedic surgery. Ann Pharmacother 2004;38:377-82. Epub 12 Jan 2004. DOI 10.1345/aph.1C518
4. Ginsberg JS, Gent M, Turkstra F, et al. Postthrombotic syndrome after hip or knee arthroplasty. Arch Intern Med 2000;160:669-72.
5. Kahn SR, Hirsch A, Shrier I. Effect of postthrombotic syndrome on health-related quality of life after deep vein thrombosis. Arch Intern Med 2002;162:1144-8.
6. Sullivan SD, Davidson BL, Kahn SR, Muntz JE, Oster G, Raskob G. A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery. Pharmacoeconomics 2004;22:605-20.
7. Douketis JD, Eikelboom JW, Quinlan DJ, et al. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes. Arch Intern Med 2002;162:1465-71.
8. White RH, Romano PS, Zhou H, et al. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 1998;158:1525-31.
9. Spencer FA, Lessard D, Emery C, Reed G, Goldberg RJ. Thromboembolism in the outpatient setting. Arch Intern Med 2007;167:1471-5.
10. PharMetrics, Inc. www.imshealth.com/web/home/0,3153,76485805_63872702,00. html (accessed 2007 Sept 6).
11. Caprini JA, Botteman MF, Stephens JM, et al. Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States. Value Health 2003;6:59-74.
12. Spyropoulos A. Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations. J Manag Care Pharm 2007;13:475-86.
13. Francis CW, Pellegrini VD Jr, Totterman S, et al. Prevention of deep-vein thrombosis after total hip arthroplasty. Comparison of warfarin and dalteparin. J Bone Joint Surg Am 1997;79:1365-72.
14. Howard AW, Aaron SD. Low molecular weight heparin decreases proximal and distal deep venous thrombosis following total knee arthroplasty. A meta-analysis of randomized trials. Thromb Haemost 1998;79:902-6.
15. Brookenthal KR, Freedman KB, Lotke PA, Fitzgerald RH, Lonner JH. A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty. J Arthroplasty 2001;16:293-300.
16. Shorr AF, Horblyuk R, Farrelly E, Happe LE. Costs and outcomes of post-discharge prophylaxis following major orthopedic surgery (abstract). Chest 2007;132:500a.